Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Neuropharmacology ; 144: 312-318, 2019 01.
Article in English | MEDLINE | ID: mdl-30449732

ABSTRACT

The role of the calcium-permeable AMPA receptor (CP-AMPAR) in synaptic plasticity is well established. CP-AMPAR is believed to be recruited to synapse when the memory trace is in a plastic state; however, the direct implications of its expression for memory processes is less known. Here, we investigated the contribution of CP-AMPAR expressed in the basolateral amygdala (BLA) and hippocampus (HPC) in consolidation of different types of memory, retrieval and memory update. We showed that CP-AMPAR blockade by NASPM in the BLA and HPC impaired fear memory consolidation. NASPM infusion in the HPC also impaired spatial memory consolidation in the water maze, whereas consolidation of object location memory was not affected. We found evidence of the CP-AMPAR involvement in the BLA and in the HPC upon memory retrieval. Furthermore, memory update was affected by NASPM infusion in the HPC in both immediate shock deficit and water maze reversal learning tasks. Our data indicate that the activity of CP-AMPAR in the BLA and HPC is required for the consolidation of emotional memories. Moreover, this receptor activity is required for memory retrieval in the BLA and HPC. These findings support that CP-AMPAR has a key function in memory states in which plastic changes are presumably higher, such as the beginning of memory consolidation, and retrieval-induced updating.


Subject(s)
Memory Consolidation/physiology , Mental Recall/physiology , Receptors, AMPA/metabolism , Animals , Basolateral Nuclear Complex/drug effects , Basolateral Nuclear Complex/metabolism , Calcium/metabolism , Excitatory Amino Acid Antagonists/pharmacology , Fear/drug effects , Fear/physiology , Hippocampus/drug effects , Hippocampus/metabolism , Male , Memory Consolidation/drug effects , Mental Recall/drug effects , Rats, Wistar , Receptors, AMPA/antagonists & inhibitors , Reversal Learning/drug effects , Reversal Learning/physiology , Spatial Memory/drug effects , Spatial Memory/physiology , Spermine/analogs & derivatives , Spermine/pharmacology
2.
J Cereb Blood Flow Metab ; 35(12): 1937-49, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26104286

ABSTRACT

Acute ischemic stroke is a cerebrovascular accident and it is the most common cause of physical disabilities around the globe. Patients may present with repeated ictuses, experiencing mental consequences, such as depression and cognitive disorders. Cyclin-dependent kinase 5 (CDK5) is a kinase that is involved in neurotransmission and plasticity, but its dysregulation contributes to cognitive disorders and dementia. Gene therapy targeting CDK5 was administered to the right hippocampus of ischemic rats during transient cerebral middle artery occlusion. Physiologic parameters (blood pressure, pH, pO2, and pCO2) were measured. The CDK5 downregulation resulted in neurologic and motor improvement during the first week after ischemia. Cyclin-dependent kinase 5 RNA interference (RNAi) prevented dysfunctions in learning, memory, and reversal learning at 1 month after ischemia. These observations were supported by the prevention of neuronal loss, the reduction of microtubule-associated protein 2 (MAP2) immunoreactivity, and a decrease in astroglial and microglia hyperreactivities and tauopathy. Additionally, CDK5 silencing led to an increase in the expression of brain-derived neurotrophic factor (BDNF), its Tropomyosin Receptor kinase B (TRKB) receptor, and activation of cyclic AMP response element-binding protein (CREB) and extracellular signal-regulated kinase (ERK), which are important targets in neuronal plasticity. Together, our findings suggest that gene therapy based on CDK5 silencing prevents cerebral ischemia-induced neurodegeneration and motor and cognitive deficits.


Subject(s)
Brain Ischemia/complications , Cognition Disorders/etiology , Cognition Disorders/prevention & control , Cyclin-Dependent Kinase 5/genetics , Cyclin-Dependent Kinase 5/metabolism , Hippocampus/pathology , Nerve Degeneration/genetics , Nerve Degeneration/prevention & control , Stroke/complications , Animals , Blood Pressure , Brain Chemistry/genetics , Brain Ischemia/pathology , Brain Ischemia/psychology , Carbon Dioxide/blood , Gene Knockdown Techniques , Hydrogen-Ion Concentration , Learning Disabilities/etiology , Learning Disabilities/prevention & control , Learning Disabilities/psychology , Male , Maze Learning , Memory Disorders/etiology , Memory Disorders/prevention & control , Memory Disorders/psychology , Movement Disorders/etiology , Movement Disorders/prevention & control , Movement Disorders/psychology , Nerve Degeneration/pathology , Oxygen/blood , RNA Interference , Rats , Reversal Learning/drug effects , Stroke/pathology , Stroke/psychology
3.
Neurobiol Learn Mem ; 97(2): 271-5, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22266268

ABSTRACT

We investigated the effect of the intra-CA1 administration of the D1/D5 receptor antagonist SCH23390 and the D1/D5 receptor agonist SKF38393 on spatial memory in the water maze. When given immediately, but not 3h after training, SCH23390 hindered long-term spatial memory formation without affecting non-spatial memory or the normal functionality of the hippocampus. On the contrary, post-training infusion of SKF38393 enhanced retention and facilitated the spontaneous recovery of the original spatial preference after reversal learning. Our findings demonstrate that hippocampal D1/D5 receptors play an essential role in spatial memory processing.


Subject(s)
Hippocampus/metabolism , Maze Learning/physiology , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D5/metabolism , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Benzazepines/pharmacology , Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Hippocampus/drug effects , Male , Maze Learning/drug effects , Rats , Rats, Wistar , Reversal Learning/drug effects , Reversal Learning/physiology
4.
Neurotoxicol Teratol ; 27(2): 299-310, 2005.
Article in English | MEDLINE | ID: mdl-15734280

ABSTRACT

Experimental models and clinical data indicate that the incidence of motor and learning disorders may be increased in children of epileptic mothers taking phenytoin (PHT) during pregnancy. There is little data on the vulnerability of infants to PHT-induced long-term behavioral toxicity after gestational or early life exposure (i.e., infantile convulsion therapy). We examined the persistence of alterations in circling behavior induced by exposure to PHT during gestation, infancy, or both. Pregnant Sprague-Dawley rats were injected i.p. with saline (SAL) or PHT (30 mg/kg/day) during gestational days (GD) 10-18. The offspring were then administered (i.p.) SAL or PHT (60 mg/kg/day) during postnatal days (PD) 13-23. Afterward, Circling Training tests were performed at three time points. At PD40 and PD80, the clockwise direction of circling was reinforced. At PD150, counterclockwise circling was rewarded instead. At PD40, all PHT-treated groups demonstrated increased circling velocities compared to saline-treated controls. Higher spatial error rates for direction of circling were also observed in gestation-only and infancy-only exposures. At PD80, groups exposed during gestation had higher circling velocities than control or infancy-only exposed groups. At PD150, increases in circling velocity were apparent for the reverse learning task in groups exposed during gestation. These results indicate that early postnatal exposure to PHT may exacerbate the known long-term behavioral effects of gestational exposure.


Subject(s)
Anticonvulsants/toxicity , Learning Disabilities/chemically induced , Motor Activity/drug effects , Phenytoin/toxicity , Prenatal Exposure Delayed Effects , Age Factors , Animals , Animals, Newborn , Behavior, Animal/drug effects , Birth Weight/drug effects , Female , Litter Size/drug effects , Maternal Behavior/drug effects , Pregnancy , Rats , Rats, Sprague-Dawley , Reversal Learning/drug effects , Spatial Behavior/drug effects , Stereotyped Behavior/drug effects , Survival Analysis
5.
Pharmacol Biochem Behav ; 73(3): 623-9, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12151037

ABSTRACT

Propionic acidemia is an inherited neurometabolic disorder characterized by progressive neurological deterioration with psychomotor delay/mental retardation, convulsions and coma, and whose pathophysiology is poorly unknown. In the present study, we investigated the effect of chronic administration (from the 5th to the 28th days of life) of propionic acid (PA), the major metabolite accumulating in tissues of patients affected by propionic acidemia, on the cognitive performance of adult rats in the Morris water maze task. PA doses ranged from 1.44 to 1.92 micromol/g body weight as a function of animal age. Control rats were treated with saline in the same volumes. Chronic postnatal days (5-28) PA treatment had no effect on body weight. However, it impaired spatial performance in the water maze. We also determined the effect of ascorbic acid (AA) administered, alone or combined with PA, on the same behavioral parameters in order to test whether free radicals could be responsible for the behavioral alterations observed in PA-treated animals. AA was able to prevent the behavioral alterations provoked by PA, implying that oxidative stress may be involved in these effects. Furthermore, we also investigated the total radical-trapping antioxidant potential (TRAP) in the hippocampus of the animals. We observed that TRAP was significantly reduced in the brain of propionic acidemic rats and that co-administration of AA prevented this effect. The results provide evidence that early PA treatment induces long-lasting behavioral deficits, which are possibly caused by oxygen reactive species generation, and suggest that oxidative stress may be involved in the neuropathology of propionic acidemia.


Subject(s)
Ascorbic Acid/pharmacology , Cognition Disorders/prevention & control , Free Radical Scavengers/pharmacology , Maze Learning/drug effects , Propionates/antagonists & inhibitors , Animals , Body Weight/drug effects , Cognition Disorders/chemically induced , Hippocampus/drug effects , Male , Propionates/toxicity , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Reversal Learning/drug effects , Swimming/physiology , Swimming/psychology
6.
Behav Brain Res ; 85(1): 117-20, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9095345

ABSTRACT

The aim of this study was to investigate if the neuropeptide substance P (SP) can improve learning and memory in goldfish (Carassius auratus). Four groups of fish were trained for seven days to find food in one out of two compartments until discrimination was achieved. On the last training day, they were injected (intra-abdominal) with haloperidol or vehicle before the training, and with SP or vehicle immediately after the training session. Each group of fish received either: (1) vehicle+vehicle (n = 18); (2) vehicle + SP, (n = 20, SP 50 mg/kg); (3) haloperidol+ vehicle (n = 15, haloperidol 2 mg/kg); or (4) haloperidol+ SP (n = 14, haloperidol 2 mg/kg, SP 50 mg/kg). Twenty-four hours later, the time spent to find the food was recorded. Reversal training was done for four consecutive days after this post-injection test and the time spent to find the food was recorded again. The results indicate that only the group treated with vehicle + SP needed more time to reach reversal training than control fish (Mann-Whitney U-test, P = 0.0009). It is suggested that SP can enhance memory in fish and that this effect may have a dopaminergic mediation in discrimination learning task.


Subject(s)
Goldfish/physiology , Learning/drug effects , Memory/drug effects , Substance P/pharmacology , Animals , Appetite/physiology , Discrimination Learning/drug effects , Dopamine/physiology , Dopamine Antagonists/pharmacology , Haloperidol/pharmacology , Injections, Intraventricular , Reversal Learning/drug effects , Substance P/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL